JP2004081196A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004081196A5 JP2004081196A5 JP2003057943A JP2003057943A JP2004081196A5 JP 2004081196 A5 JP2004081196 A5 JP 2004081196A5 JP 2003057943 A JP2003057943 A JP 2003057943A JP 2003057943 A JP2003057943 A JP 2003057943A JP 2004081196 A5 JP2004081196 A5 JP 2004081196A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- salt
- seq
- polynucleotide
- partial peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 description 22
- 102000004169 proteins and genes Human genes 0.000 description 20
- 150000003839 salts Chemical class 0.000 description 19
- 239000002157 polynucleotide Substances 0.000 description 13
- 102000040430 polynucleotide Human genes 0.000 description 13
- 108091033319 polynucleotide Proteins 0.000 description 13
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- 125000003275 alpha amino acid group Chemical group 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 239000000032 diagnostic agent Substances 0.000 description 3
- 229940039227 diagnostic agent Drugs 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003057943A JP2004081196A (ja) | 2002-03-06 | 2003-03-05 | 新規タンパク質およびそのｄｎａ |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002061133 | 2002-03-06 | ||
| JP2002098852 | 2002-04-01 | ||
| JP2002184883 | 2002-06-25 | ||
| JP2003057943A JP2004081196A (ja) | 2002-03-06 | 2003-03-05 | 新規タンパク質およびそのｄｎａ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004081196A JP2004081196A (ja) | 2004-03-18 |
| JP2004081196A5 true JP2004081196A5 (enExample) | 2006-03-02 |
Family
ID=32074555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003057943A Pending JP2004081196A (ja) | 2002-03-06 | 2003-03-05 | 新規タンパク質およびそのｄｎａ |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2004081196A (enExample) |
-
2003
- 2003-03-05 JP JP2003057943A patent/JP2004081196A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007297407A5 (enExample) | ||
| JP2005538932A5 (enExample) | ||
| WO2001034809A3 (en) | Staphylococcus epidermidis nucleic acids and proteins | |
| WO2005040418A3 (en) | Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wnt | |
| JP2006502702A5 (enExample) | ||
| JP2006158399A5 (ja) | 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤 | |
| JP2004081196A5 (enExample) | ||
| DE60143608D1 (de) | Neueskollagen-ähnliches protein clac, dessen vorläufer und dafür kodierende gene | |
| WO2003076658A3 (en) | A susceptibility gene for late-onset idiopathic parkinson's disease | |
| WO2001064876A3 (en) | Human schizophrenia gene | |
| JP2009507474A5 (enExample) | ||
| US20250326795A1 (en) | Use of d-enantiomeric peptide ligands of monomeric tau for the therapy of various tauopathies | |
| JP2008522632A5 (enExample) | ||
| JP2005006644A5 (enExample) | ||
| JP2004533848A5 (enExample) | ||
| JP2001069994A5 (enExample) | ||
| JP2002335976A5 (enExample) | ||
| JP2002335964A5 (enExample) | ||
| JP2004073182A5 (enExample) | ||
| MXPA05009954A (es) | Familia de proteinas secretadas. | |
| JP2003079381A5 (enExample) | ||
| JP2002355060A5 (enExample) | ||
| JP2003144177A5 (enExample) | ||
| JP2003315332A5 (enExample) | ||
| WO2002070559A3 (en) | Nuclear hormone receptor ligand binding domains |